DCM
TXMD icon

Daruma Capital Management’s TherapeuticsMD TXMD Stock Holding History

Daruma Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-142,221
Closed -$34.6M – 31
2019
Q1 		$34.6M Buy
142,221
+15,005
+12% +$3.97M 3.94% 4
2018
Q4 		$24.2M Buy
127,216
+36,425
+40% +$8.88M 3.23% 13
2018
Q3 		$29.8M Buy
+90,791
New +$27.8M 2.81% 20

Other funds holding TXMD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Daruma Capital Management's TXMD Position: Q2 2019 in Review

Daruma Capital Management sold out of TherapeuticsMD (TXMD) in Q2 2019, closing a stake of 142,221 shares — an estimated $34.6M sold.

Daruma Capital Management first reported a position in TXMD in Q3 2018 and held it in 3 quarters. The position peaked at $34.6M in Q1 2019. 148 funds tracked by Wall St. Rank hold TXMD as of Q2 2019.

  • Daruma Capital Management reported no remaining TherapeuticsMD position as of Q2 2019 after selling out during the quarter.
  • Daruma Capital Management sold 142,221 TherapeuticsMD shares in Q2 2019, an estimated $34.6M.
  • Daruma Capital Management first reported a position in TherapeuticsMD in Q3 2018 and held it in 3 quarters.
  • Daruma Capital Management's TherapeuticsMD position peaked at $34.6M in Q1 2019.
  • 148 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2019.

Based on Daruma Capital Management's 13F filing for Q2 2019.